Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
NCT ID: NCT01058369
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01058369
Study Brief: Exjade-Early-Trial
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Deferasirox Deferasirox (Novartis Pharma): Treatment period 102 weeks. Starting dose 10mg/kg/day. Up to 30/mg/kg according to dose adjustment table as specified in the protocol None None 1 2 2 2 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pneumonia None Respiratory, thoracic and mediastinal disorders MedDRA (Unspecified) View
acute myeloid leukaemia None Blood and lymphatic system disorders MedDRA (Unspecified) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
back pain None Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
petechiae None Skin and subcutaneous tissue disorders MedDRA (Unspecified) View
haematoma None Vascular disorders MedDRA (Unspecified) View
thrombophlebitis None Vascular disorders MedDRA (Unspecified) View
fatigue None General disorders MedDRA (Unspecified) View
dyspnea None Respiratory, thoracic and mediastinal disorders MedDRA (Unspecified) View
depression None Psychiatric disorders MedDRA (Unspecified) View
wound None Injury, poisoning and procedural complications MedDRA (Unspecified) View
nausea None Gastrointestinal disorders MedDRA (Unspecified) View
dyspepsia None Gastrointestinal disorders MedDRA (Unspecified) View
abdominal pain upper None Gastrointestinal disorders MedDRA (Unspecified) View
hypertension None Vascular disorders MedDRA (Unspecified) View
emotional distress None Psychiatric disorders MedDRA (Unspecified) View
pain in extremity None Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
gingival bleeding None Vascular disorders MedDRA (Unspecified) View